Priscila Marinho de Abreu

Priscila Marinho de Abreu

Auto-generated profile, based on publicly available information

Priscila Marinho de Abreu

Biotechnology Post-Graduation Program, Health Sciences Center, Federal University of Espírito Santo, Vitória 29040-090, Espírito Santo, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PAPriscila Marinho de Abreu
Priscila Marinho de Abreu
ACAnna Clara Gregório Có
Anna Clara Gregório Có
PAPedro Leite Azevedo
Pedro Leite Azevedo
IVIsabella Bittencourt Do Valle
Isabella Bittencourt Do Valle
KOKarine Gadioli de Oliveira
Karine Gadioli de Oliveira
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler
The prevalence of high-risk human papillomavirus (HPV) DNA in cases of oral cavity squamous cell carcinoma (SCC) varies widely. The aim of this study is to investigate the frequency of high-risk HPV DNA in a large Brazilian cohort of patients with oral cavity SCC. Biopsy and resected frozen and formalin-fixed paraffin-embedded specimens of oral cavity SCC were available from 101 patients who were recruited at two Brazilian centres. Stringent measures with respect to case selection and prevention of sample contamination were adopted to ensure reliability of the data. Nested PCR using MY09/MY11 and GP5+/GP6+ as well as PGMY09/11 L1 consensus primers were performed to investigate the presence of HPV DNA in the tumours. HPV-positive cases were subjected to direct sequencing. Shapiro–Wilk and Student t test were used to evaluate data normality and to compare the means, respectively. Qualitative variables were analysed by logistic regression. Our results demonstrate that the frequency of high-risk HPV types in oral cavity SCC is very low and is less than 4%. All HPV-positive cases were HPV16. In addition, our results do not show a significant association between the tumour clinical features and the risk factors (tobacco, alcohol and HPV) for oral cavity SCC. In the current study, we observed an overlapping pattern of risk factors that are related to tumour development. This, along with a low frequency of high-risk HPV DNA, supports the findings that HPV is not involved in the genesis of oral cavity SCC in Brazilian population.

1 August 2020 in Archives of Oral Biology
Verified
Journal Article
Closed access
PAPriscila Marinho Abreu
Priscila Marinho Abreu
IVIsabella Bittencourt Valle
Isabella Bittencourt Valle
TDThabata Coeli Dias Damasceno
Thabata Coeli Dias Damasceno
ACAnna Clara Gregório Có
Anna Clara Gregório Có
PPPaola Fernandes Pansini
Paola Fernandes Pansini
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler

11 April 2021 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
PPPaola Fernandes Pansini
Paola Fernandes Pansini
IVIsabella Bittencourt Do Valle
Isabella Bittencourt Do Valle
TDThabata Coeli Dias Damasceno
Thabata Coeli Dias Damasceno
PAPriscila Marinho de Abreu
Priscila Marinho de Abreu
ACAnna Clara Gregório Có
Anna Clara Gregório Có
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler

18 October 2024 in Cancer Epidemiology
Verified
Journal Article
Closed access
JSJéssica Graça Sant’anna
Jéssica Graça Sant’anna
MOMax Moura de Oliveira
Max Moura de Oliveira
PAPriscila Marinho Abreu
Priscila Marinho Abreu
WZWillene dos Santos Machado Zorzaneli
Willene dos Santos Machado Zorzaneli
CDCamila Daniel
Camila Daniel
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler

28 February 2026 in Clinics
Verified
Journal Article
Open access
BABrena Ramos Athaydes
Brena Ramos Athaydes
MMMariane Vedovatti Monfardini
Mariane Vedovatti Monfardini
PAPriscila Marinho Abreu
Priscila Marinho Abreu
FFFrederico Firme Figueira
Frederico Firme Figueira
JCJuliana Couto-Vieira
Juliana Couto-Vieira
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler
This prospective cohort study describes clinical, laboratory factors and virological factors associated with in-hospital mortality among 227 Intensive Care Unit (ICU) patients with SARS-CoV-2 infection admitted in Brazil during the pre-vaccination, pre-Omicron phase of the pandemic (September 2020 to March 2021). Clinical and laboratory data were extracted from medical records, and viral load was quantified by RT-qPCR Cycle threshold (Ct) values. Independent predictors of mortality were evaluated using multivariable Cox proportional hazards regression, and survival was analyzed with Kaplan-Meier curves. Non-survivors were significantly older (p < 0.001) and more likely to have hypertension (p = 0.014) and chronic respiratory disease (p = 0.042). At admission, they exhibited higher leukocyte counts (p = 0.001), D-dimer (p = 0.028), and creatinine levels (p = 0.001), as well as more frequent tracheal intubation (p < 0.001). During hospitalization, non-survivors showed persistently elevated leukocyte counts and developed more complications, including acute kidney injury, septic shock, and cardiac arrest (p < 0.001). Viral load was higher in non-survivors (p = 0.026) and among those requiring intubation (p = 0.042) or with cardiovascular disease (p = 0.016). In the multivariable Cox model, only creatinine at admission remained independently associated with mortality (HR = 1.18; 95% CI: 1.00-1.39; p = 0.049). Survival analysis showed reduced survival among patients aged ≥ 65-years (p = 0.004) and those with chronic respiratory disease (p = 0.029). This study integrates clinical, laboratory, and viral load data to detail the early COVID-19 severity and mortality patterns in a Brazilian ICU.

Verified
Journal Article
Open access
PDF file
EXEnes Buck Mutiua Cantala Xavier
Enes Buck Mutiua Cantala Xavier
CDCamila Daniel
Camila Daniel
PAPriscila Marinho de Abreu
Priscila Marinho de Abreu
IVIsabella Bittencourt Do Valle
Isabella Bittencourt Do Valle
BABrena Ramos Athaydes
Brena Ramos Athaydes
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler
Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) remains a global public health challenge with significant morbidity and mortality. Emerging epidemiological data indicate a rising global incidence of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). Serology for early HPV antigens has been highlighted as a relevant biomarker for HPV-associated OPSCC. This study aimed to determine the seroprevalence of HPV16 E6 antibodies in HNSCC patients in the state of Espírito Santo, Brazil. Methods: This is a prospective longitudinal cohort study in which 287 patients with HNSCC were enrolled, recruited from two oncology centers in Espírito Santo between 2011 and 2018, along with 68 cancer-free individuals. Serum samples were analyzed using the HPV16 E6 GST Capture ELISA assay. Statistical analysis was performed using SPSS. Binary logistic regression was employed to identify independent predictors of seropositivity. Results: The overall seroprevalence of HPV16 E6 antibodies was 7.3%. Seropositivity was observed in tumors of the oral cavity (6.2%) and oropharynx (13.3%). Patients with OPSCC demonstrated a significantly higher likelihood of seropositivity compared to those with tumors of the oral cavity, larynx, and hypopharynx (OR = 2.96, 95% CI: 1.21–7.28, p = 0.018). The highest frequency of HPV16 E6-positive cases occurred in tumors of the palatine tonsils (OR = 6.00; 95% CI: 1.58–22.89; p < 0.009). No seropositive cases were observed in hypopharyngeal or laryngeal tumors. Among patients with OPSCC and oral cavity squamous cell carcinoma (OCSCC), HPV16 E6 serostatus did not significantly correlate with sociodemographic, behavioral, or clinical tumor characteristics. Conclusions: Our findings reinforce the predilection of HPV-associated carcinogenesis for the oropharynx, more specifically in the palatine tonsils. In addition, this study highlights HPV16 E6 serology as a potential biomarker for HPV-driven OPSCC and underscores Brazil’s epidemiological heterogeneity, warranting standardized clinical validation.